Class information for:
Level 1: THROMBOMODULIN//SOLUBLE THROMBOMODULIN//PLASMA THROMBOMODULIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
11733 894 35.4 84%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
261 18876 PROTEIN C//ACTIVATED PROTEIN C//TISSUE FACTOR

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 THROMBOMODULIN Author keyword 174 40% 39% 346
2 SOLUBLE THROMBOMODULIN Author keyword 12 45% 2% 20
3 PLASMA THROMBOMODULIN Author keyword 6 100% 0% 4
4 THROMBOMODULIN TM Author keyword 2 38% 1% 5
5 ART PROJECT Address 2 50% 0% 3
6 PROTEIN C ACTIVATION Author keyword 2 43% 0% 3
7 PROTEIN C PATHWAY Author keyword 1 19% 1% 5
8 THROMBOSIS HAEMOSTASIS VASC BIOL UNIT Address 1 40% 0% 2
9 AGING DRUG SCI Address 1 50% 0% 1
10 ANTI HCV SEROPOSITIVITY Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 THROMBOMODULIN 174 40% 39% 346 Search THROMBOMODULIN Search THROMBOMODULIN
2 SOLUBLE THROMBOMODULIN 12 45% 2% 20 Search SOLUBLE+THROMBOMODULIN Search SOLUBLE+THROMBOMODULIN
3 PLASMA THROMBOMODULIN 6 100% 0% 4 Search PLASMA+THROMBOMODULIN Search PLASMA+THROMBOMODULIN
4 THROMBOMODULIN TM 2 38% 1% 5 Search THROMBOMODULIN+TM Search THROMBOMODULIN+TM
5 PROTEIN C ACTIVATION 2 43% 0% 3 Search PROTEIN+C+ACTIVATION Search PROTEIN+C+ACTIVATION
6 PROTEIN C PATHWAY 1 19% 1% 5 Search PROTEIN+C+PATHWAY Search PROTEIN+C+PATHWAY
7 ANTI HCV SEROPOSITIVITY 1 50% 0% 1 Search ANTI+HCV+SEROPOSITIVITY Search ANTI+HCV+SEROPOSITIVITY
8 ANTITHROMBIN RESISTANCE 1 50% 0% 1 Search ANTITHROMBIN+RESISTANCE Search ANTITHROMBIN+RESISTANCE
9 DRUG ELUTING STENTS ADVERSE EFFECTS 1 50% 0% 1 Search DRUG+ELUTING+STENTS+ADVERSE+EFFECTS Search DRUG+ELUTING+STENTS+ADVERSE+EFFECTS
10 ENDOTHELIAL INJURY MARKERS 1 50% 0% 1 Search ENDOTHELIAL+INJURY+MARKERS Search ENDOTHELIAL+INJURY+MARKERS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PLASMA THROMBOMODULIN 62 50% 10% 89
2 SOLUBLE THROMBOMODULIN 58 54% 9% 76
3 RECOMBINANT HUMAN THROMBOMODULIN 37 58% 5% 43
4 FETOMODULIN 35 89% 2% 16
5 THROMBIN CATALYZED ACTIVATION 28 33% 8% 71
6 NATURAL ANTICOAGULANT 26 53% 4% 34
7 LECTIN LIKE DOMAIN 18 36% 5% 41
8 SERUM THROMBOMODULIN 16 60% 2% 18
9 RABBIT THROMBOMODULIN 16 46% 3% 26
10 PROTEIN C ACTIVATION 16 23% 7% 62

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Thrombomodulin and its role in inflammation 2012 50 247 45%
Thrombomodulin-protein C-EPCR system - Integrated to regulate coagulation and inflammation 2004 168 105 44%
Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects 2013 14 179 47%
Thrombomodulin Links Coagulation to Inflammation and Immunity 2012 18 123 69%
The role of thrombomodulin lectin-like domain in inflammation 2012 13 52 54%
Recombinant Thrombomodulin of Different Domains for Pharmaceutical, Biomedical, and Cell Transplantation Applications 2014 1 140 66%
Structural and functional consequences of methionine oxidation in thrombomodulin 2005 23 19 68%
Thrombomodulin: tumour biology and prognostic implications 2005 15 40 80%
Thrombomodulin as a regulator of the anticoagulant pathway: implication in the development of thrombosis 2012 8 116 58%
Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation 2011 36 51 22%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ART PROJECT 2 50% 0.3% 3
2 THROMBOSIS HAEMOSTASIS VASC BIOL UNIT 1 40% 0.2% 2
3 AGING DRUG SCI 1 50% 0.1% 1
4 CHILDRENS HOSP MED NEUROSURG 1 50% 0.1% 1
5 DMCO OSPED SAN PAOLO 1 50% 0.1% 1
6 HOKUSOH HOSP 1 50% 0.1% 1
7 INSERM 428 1 50% 0.1% 1
8 MED SURG 2 AOBA KU 1 50% 0.1% 1
9 OKLAHOMA MED FDN BIOCHEM MOL BIOL 1 50% 0.1% 1
10 OKLAHOMA MED FDN PATHOL 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000193449 ACTIVATED PROTEIN C//ENDOTHELIAL PROTEIN C RECEPTOR//DROTRECOGIN ALFA ACTIVATED
2 0.0000140237 PATHOL HSC4N67//LIVER CLEARANCE//SERP 1
3 0.0000139221 PROTEIN S//PROTEIN C DEFICIENCY//C4B BINDING PROTEIN
4 0.0000114878 TAFI//CARBOXYPEPTIDASE U//THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR
5 0.0000088174 FACTOR V DEFICIENCY//FACTOR VA//FACTOR V
6 0.0000072895 ENDOSIALIN//CD248//TEM1
7 0.0000069316 UNITAT ANAT HUMANA EMBRIOL//UNITAT MED MATERNO FETAL//THROMBIN ANTITHROMBIN COMPLEXES
8 0.0000068056 PROTEIN C INHIBITOR//MCFD2//F5F8D
9 0.0000067760 HIRUDIN//FACTOR XA//THROMBIN INHIBITOR
10 0.0000063398 TISSUE FACTOR//TISSUE FACTOR PATHWAY INHIBITOR//TFPI